Some startups have also raised investments in recent years. However, local players like Molbio, Mylab, and TATA MD are striving to make their place in the Indian molecular diagnostics market. The global diagnostics market is dominated by players like Roche and Abbott. The PCR segment dominated the infectious disease molecular diagnostics market and accounted for approximately 90% of revenue in 2020. ![]() Perinatal screening and predictive testing are two important areas where molecular diagnostics will play a significant role in the future. The report also sheds light on the emerging applications of molecular diagnostics in genetics, hematopathology, cardiovascular diseases, and neurological diseases. The report highlights the potential of molecular diagnostics to improve patient outcomes with predictive medicine, early diagnosis, and monitoring the efficacy of treatment modalities.Īccording to the report titled ‘Molecular diagnostics – a way forward to improve patient health’, the molecular diagnostics market in India is expected to reach about US$ 1.6 Billion by 2030, driven by growing interest from investors, corporates, and startups. This has resulted in increased adoption of molecular diagnostic tests by healthcare providers, and even common people becoming familiar with terms like RT-PCR. ![]() Mumbai, April ’23: Molecular diagnostics has gained widespread recognition as a highly accurate and sensitive method for the early detection of infectious diseases, including COVID-19.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |